Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 5,964 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $21,887.88. Following the sale, the chief executive officer now owns 186,904 shares in the company, valued at approximately $685,937.68. The trade was a 3.09 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Amit Gupta also recently made the following trade(s):
- On Thursday, October 24th, Amit Gupta sold 22,607 shares of Cardlytics stock. The stock was sold at an average price of $3.85, for a total value of $87,036.95.
Cardlytics Stock Performance
NASDAQ CDLX opened at $3.35 on Thursday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a fifty day simple moving average of $3.89 and a 200 day simple moving average of $4.77. Cardlytics, Inc. has a 12-month low of $2.89 and a 12-month high of $20.52. The company has a market cap of $170.25 million, a P/E ratio of -0.55 and a beta of 1.53.
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently modified their holdings of the stock. Check Capital Management Inc. CA grew its holdings in Cardlytics by 10.4% during the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock worth $162,000 after buying an additional 4,775 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in Cardlytics by 32.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock valued at $63,000 after acquiring an additional 4,796 shares in the last quarter. Creative Planning boosted its holdings in Cardlytics by 35.4% during the 3rd quarter. Creative Planning now owns 29,537 shares of the company’s stock worth $95,000 after acquiring an additional 7,721 shares during the last quarter. Atom Investors LP bought a new stake in shares of Cardlytics in the 3rd quarter worth $33,000. Finally, Quest Partners LLC raised its holdings in shares of Cardlytics by 160.4% in the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after purchasing an additional 11,061 shares during the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently commented on CDLX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Finally, Evercore ISI began coverage on shares of Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $6.92.
Read Our Latest Stock Analysis on Cardlytics
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
See Also
- Five stocks we like better than Cardlytics
- Why Invest in High-Yield Dividend Stocks?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Most active stocks: Dollar volume vs share volume
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Are Dividend Contenders? Investing in Dividend Contenders
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.